当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析

恒瑞医药

(600276)

  

流通市值:3397.46亿  总市值:3534.97亿
流通股本:63.79亿   总股本:66.37亿

恒瑞医药(600276)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润18.76亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益4754976.91万元,未分配利润3573958.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产5129278.17万元,负债374301.26万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入7,205,611,122.7227,984,605,342.0620,189,303,845.113,600,734,114.77
营业总成本5,134,690,588.221,008,000,532.0315,089,979,241.89,756,000,390.11
营业利润2,085,980,911.667,490,632,003.885,345,290,528.733,984,776,115.54
利润总额2,075,603,711.837,169,689,995.755,086,740,155.233,751,600,104.87
净利润1,876,441,961.326,336,994,647.534,616,330,177.463,428,132,358.04
其他综合收益2,346,805.44-624,026.11-12,630,993.15-17,226.74
综合收益总额1,878,788,766.766,336,370,621.424,603,699,184.313,428,115,131.3
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计35,969,765,897.935,314,927,240.5934,456,969,388.1634,776,635,798.26
非流动资产合计15,323,015,793.0114,820,718,063.5113,881,130,024.5613,404,724,245.31
资产总计51,292,781,690.9150,135,645,304.148,338,099,412.7248,181,360,043.57
流动负债合计3,362,881,494.13,633,595,722.673,829,566,410.174,808,305,486.21
非流动负债合计380,131,139.07411,798,848.12177,014,307.13185,918,401.38
负债合计3,743,012,633.174,045,394,570.794,006,580,717.34,994,223,887.59
归属于母公司股东权益合计46,987,059,491.0845,519,861,860.3243,767,908,821.7542,622,242,805.08
股东权益合计47,549,769,057.7446,090,250,733.3144,331,518,695.4243,187,136,155.98
负债和股东权益合计51,292,781,690.9150,135,645,304.148,338,099,412.7248,181,360,043.57
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计6,301,936,538.2928,468,881,744.1320,546,797,062.713,838,319,569.27
经营活动现金流出小计5,746,762,449.7821,046,128,705.4215,961,351,053.5810,805,564,728.09
经营活动产生的现金流量净额555,174,088.517,422,753,038.714,585,446,009.123,032,754,841.18
投资活动现金流入小计170,354,321.21679,892,183.13251,221,022.4541,081,305.06
投资活动现金流出小计702,031,901.522,591,877,899.362,124,667,512.241,564,673,726.04
投资活动产生的现金流量净额-531,677,580.31-1,911,985,716.23-1,873,446,489.79-1,523,592,420.98
筹资活动现金流入小计-799,909,380.08799,909,380.08799,909,380.08
筹资活动现金流出小计661,059,213.922,350,499,405.962,306,433,430.14938,476,900.96
筹资活动产生的现金流量净额-661,059,213.92-1,550,590,025.88-1,506,524,050.06-138,567,520.88
汇率变动对现金及现金等价物的影响29,624,153.667,400,551.34-21,219,513.59-5,838,450.66
现金及现金等价物净增加额-607,938,552.063,967,577,847.941,184,255,955.681,364,756,448.66
期末现金及现金等价物余额23,631,163,565.624,239,102,117.6621,455,780,225.421,636,280,718.38
最新报告期:2025-06-20
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
首创证券王斌1.101.271.522025-06-20
天风证券杨松,曹文清1.101.261.482025-05-25
中信建投袁清慧,贺菊颖1.341.661.982025-05-25
群益证券王睿哲1.091.371.632025-05-08
中信证券陈竹,韩世通1.161.341.552025-04-29
TOP↑